Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAPDH | P04406 | 1/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.30 |
| ▸ | BLM | P54132 | 1/20 | 0.30 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.30 |
| ▸ | CA1 | P00915 | 1/20 | 0.30 |
| ▸ | CA2 | P00918 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL344979 | 1.00 | GAPDH (0.37) | GAPDHKDM4ETDP1LMNAALOX15 | |
| Lactic Acid SCHEMBL7630269 | 0.90 | TP53 (0.41) | GAPDH | |
| SCHEMBL3868756 | 0.83 | CHRM1 (0.33) | TDP1CA1CA2 | |
| SCHEMBL6055381 | 0.82 | AKR1B1 (0.39) | TDP1LMNAALOX15BLMPMP22 | |
| SCHEMBL1784421 | 0.81 | GAPDH (0.39) | GAPDHTDP1 | |
| SCHEMBL1784419 | 0.81 | GAPDH (0.39) | GAPDHTDP1 | |
| SCHEMBL711050 | 0.79 | GAPDH (0.38) | GAPDH | |
| SCHEMBL11674955 | 0.79 | KDM4E (0.42) | KDM4ETDP1LMNAALOX15BLM | |
| SCHEMBL16667 | 0.79 | GAPDH (0.38) | GAPDH | |
| SCHEMBL3868461 | 0.78 | TRPA1 (0.46) | GAPDH |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 7226 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3191534-B1 | AMPHIPHILIC BLOCK COPOLYMERS FOR DELIVERY OF ACTIVE AGENTS | RWTH AACHEN (DE) | 2025-10-01 | — | — | EP | claimed |
| CN-112601540-B | Biopharmaceutical agents for reducing lipid content in cells | 约翰内斯堡威特沃特斯兰德大学 | 2025-01-28 | — | — | CN | claimed |
| EP-3831858-B1 | VINYL CHLORIDE-BASED COPOLYMER AND METHOD FOR PREPARING SAME | HANWHA SOLUTIONS CORP (KR) | 2024-12-04 | — | — | EP | claimed |
| US-12128130-B2 | Injectable composition for preventing hair loss or stimulating hair growth | KERAMEDIX INC. (KR) | 2024-10-29 | — | — | US | claimed |
| CN-109803682-B | Monovalent asymmetric tandem Fab bispecific antibodies | 岸迈生物科技有限公司 | 2024-07-19 | — | — | CN | claimed |
| US-20240156808-A1 | Compositions and methods to improve the therapeutic benefit of suboptimally chemical compounds and biological therapies including substituted camptothecins such as irinotecan and topotecan for the treatment of benign and neoplastic hyperproliferative disease conditions, infections, inflammatory and immunological diseases | EDISON ONCOLOGY (US) | 2024-05-16 | — | — | US | claimed |
| EP-3817764-B1 | BIOPHARMACEUTICAL AGENTS FOR USE IN REDUCING LIPID CONTENT IN CELLS | UNIV JOHANNESBURG WITWATERSRAND (ZA) | 2024-04-17 | — | — | EP | claimed |
| CN-117858926-A | Oleophobic fluoropolymer and filter material prepared therefrom | 恩特格里斯公司 | 2024-04-09 | — | — | CN | claimed |
| EP-4333807-A1 | NICOTINAMIDE ADENINE DINUCLEOTIDE (NAD) COMPOSITIONS, METHODS OF MANUFACTURING THEREOF, AND METHODS OF USE THEREOF | Sovida Solutions Ltd. (GB) | 2024-03-13 | — | — | EP | claimed |
| US-11912775-B2 | Anti-human CCR1 monoclonal antibody | KYOWA KIRIN CO., LTD. (JP) | 2024-02-27 | — | — | US | claimed |
| EP-0683676-A1 | DIRECTED BIODISTRIBUTION OF SMALL MOLECULES | NEORX CORPORATION (US) | 1995-11-29 | — | — | EP | claimed |
| EP-0412770-B1 | Polysiloxane-grafted copolymer topical binder composition with novel hydrophilic monomers and method of coating therewith | MINNESOTA MINING & MFG (US) | 1995-10-04 | — | — | EP | claimed |
| WO-1994029479-A9 | OLIGONUCLEOTIDES WHICH INHIBIT HIV PROTEASE FUNCTION | — | 1995-02-02 | — | — | WO | claimed |
| WO-1994029479-A1 | OLIGONUCLEOTIDES WHICH INHIBIT HIV PROTEASE FUNCTION | PHARMAGENICS, INC. (US) | 1994-12-22 | — | — | WO | claimed |
| WO-1994020073-A1 | LIPID-POLYMER CONJUGATES AND LIPOSOMES | LIPOSOME TECHNOLOGY, INC. (US) | 1994-09-15 | — | — | WO | claimed |
| WO-1994017829-A1 | DIRECTED BIODISTRIBUTION OF SMALL MOLECULES | NEORX CORPORATION (US) | 1994-08-18 | — | — | WO | claimed |
| EP-0591233-A1 | POLYMER COATINGS | BIOINTERACTIONS LIMITED (GB) | 1994-04-13 | — | — | EP | claimed |
| WO-1994001448-A1 | OLIGONUCLEOTIDES MODIFIED WITH CONJUGATE GROUPS | PHARMAGENICS, INC. (US) | 1994-01-20 | — | — | WO | claimed |
| WO-1993023570-A1 | OLIGONUCLEOTIDES HAVING CONJUGATES ATTACHED AT THE 2'-POSITION OF THE SUGAR MOIETY | PHARMAGENICS, INC. (US) | 1993-11-25 | — | — | WO | claimed |
| WO-1993000391-A1 | POLYMER COATINGS | BIOINTERACTIONS LIMITED (GB) | 1993-01-07 | — | — | WO | claimed |